Innospec Inc. - Common Stock (IOSP)

Innospec (NASDAQ:IOSP) reported higher third-quarter revenue, earnings and operating income across its three business segments, while management said it expects continued strength in Fuel Specialties and sequential improvement in Oilfield Services during the fourth quarter. Total third-quarter reve

Working capital absorbed $80 million even as segment operating income climbed.

All three segments posted growth as revenue climbed to $491.4 million.

Innospec (NASDAQ:IOSP) reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities. Total revenue ro

Innospec (NASDAQ:IOSP) reported mixed first-quarter 2026 results, as strong performance in its Fuel Specialties segment was partially offset by disruptions tied to a January 2026 U.S. winter storm that affected operations in Performance Chemicals and, to a lesser extent, Oilfield Services. Managemen

Innospec (IOSP) Q1 2026 Earnings Transcript

This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.

Select Medical Holdings delivers rehabilitation and occupational health services through a nationwide network of hospitals and clinics.

Innospec (IOSP) Q4 2024 Earnings Transcript

Innospec (IOSP) Q4 2025 Earnings Call Transcript

Innospec's (NYSE: IOSP) short interest as a percent of float has risen 6.15% since its last report. According to exchange reported data, there are now 334 thousand shares sold short, which is 1.9% of all regular shares that are available for trading.